• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Combined effect of synthetic protein, Mini-B, and cholesterol on a model lung surfactant mixture at the air-water interface.合成蛋白Mini - B与胆固醇对气液界面处模型肺表面活性剂混合物的联合作用。
Biochim Biophys Acta. 2016 Apr;1858(4):904-12. doi: 10.1016/j.bbamem.2016.01.008. Epub 2016 Jan 15.
2
Pulmonary surfactant protein SP-C counteracts the deleterious effects of cholesterol on the activity of surfactant films under physiologically relevant compression-expansion dynamics.肺表面活性物质蛋白 SP-C 可对抗胆固醇在生理相关压缩-扩张动力学下对表面活性剂膜活性的有害影响。
Biophys J. 2009 Nov 18;97(10):2736-45. doi: 10.1016/j.bpj.2009.08.045.
3
Effects of cholesterol on surface activity and surface topography of spread surfactant films.胆固醇对铺展表面活性剂膜的表面活性和表面形貌的影响。
Biochemistry. 2002 Dec 17;41(50):15007-16. doi: 10.1021/bi0256532.
4
Effect of pulmonary surfactant protein SP-B on the micro- and nanostructure of phospholipid films.肺表面活性物质蛋白SP-B对磷脂膜微观和纳米结构的影响。
Biophys J. 2004 Jan;86(1 Pt 1):308-20. doi: 10.1016/S0006-3495(04)74106-5.
5
Effect of hydrophobic surfactant proteins SP-B and SP-C on binary phospholipid monolayers: II. Infrared external reflectance-absorption spectroscopy.疏水性表面活性蛋白SP-B和SP-C对二元磷脂单分子层的影响:II. 红外外反射-吸收光谱法
Biophys J. 2003 Jan;84(1):326-40. doi: 10.1016/S0006-3495(03)74853-X.
6
Molecular dynamics study of the effect of cholesterol on the properties of lipid monolayers at low surface tensions.胆固醇对低表面张力下脂质单分子层性质影响的分子动力学研究
Phys Chem Chem Phys. 2009 Mar 28;11(12):1916-22. doi: 10.1039/b819767a. Epub 2009 Feb 18.
7
Cholesterol modifies the properties of surface films of dipalmitoylphosphatidylcholine plus pulmonary surfactant-associated protein B or C spread or adsorbed at the air-water interface.胆固醇可改变二棕榈酰磷脂酰胆碱与肺表面活性物质相关蛋白B或C在气-水界面铺展或吸附形成的表面膜的性质。
Biochemistry. 1997 Jan 28;36(4):912-22. doi: 10.1021/bi9623542.
8
Phospholipid packing and hydration in pulmonary surfactant membranes and films as sensed by LAURDAN.通过LAURDAN检测肺表面活性物质膜和薄膜中的磷脂堆积与水合作用。
Biochim Biophys Acta. 2011 Mar;1808(3):696-705. doi: 10.1016/j.bbamem.2010.11.019. Epub 2010 Nov 30.
9
Folding of lipid monolayers containing lung surfactant proteins SP-B(1-25) and SP-C studied via coarse-grained molecular dynamics simulations.通过粗粒度分子动力学模拟研究含肺表面活性蛋白SP-B(1-25)和SP-C的脂质单层的折叠。
Biochim Biophys Acta. 2010 Sep;1798(9):1632-50. doi: 10.1016/j.bbamem.2010.04.006. Epub 2010 May 14.
10
Structure and properties of phospholipid-peptide monolayers containing monomeric SP-B(1-25) I. Phases and morphology by epifluorescence microscopy.含单体SP-B(1-25)的磷脂-肽单层膜的结构与性质I. 落射荧光显微镜观察的相和形态
Biophys Chem. 2005 Mar 1;113(3):223-32. doi: 10.1016/j.bpc.2004.09.008.

引用本文的文献

1
Evolution and mechanics of mixed phospholipid fibrinogen monolayers.混合磷脂-纤维蛋白原单层的演变和力学性质。
J R Soc Interface. 2018 Apr;15(141). doi: 10.1098/rsif.2017.0895.

本文引用的文献

1
Phospholipid composition modulates carbon nanodiamond-induced alterations in phospholipid domain formation.磷脂组成调节碳纳米金刚石诱导的磷脂结构域形成变化。
Langmuir. 2015 May 12;31(18):5093-104. doi: 10.1021/la504923j. Epub 2015 Apr 28.
2
Structure-function relationships in pulmonary surfactant membranes: from biophysics to therapy.肺表面活性物质膜的结构-功能关系:从生物物理学到治疗
Biochim Biophys Acta. 2014 Jun;1838(6):1568-85. doi: 10.1016/j.bbamem.2014.01.028. Epub 2014 Feb 11.
3
Size influences the effect of hydrophobic nanoparticles on lung surfactant model systems.尺寸影响疏水纳米颗粒对肺表面活性剂模型系统的影响。
Biophys J. 2014 Jan 7;106(1):289-98. doi: 10.1016/j.bpj.2013.10.036.
4
Effect of cholesterol nanodomains on monolayer morphology and dynamics.胆固醇纳米域对单层形态和动力学的影响。
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):E3054-60. doi: 10.1073/pnas.1303304110. Epub 2013 Jul 30.
5
Lipid-protein interactions alter line tensions and domain size distributions in lung surfactant monolayers.脂质-蛋白相互作用改变肺表面活性剂单层的线张力和畴尺寸分布。
Biophys J. 2012 Jan 4;102(1):56-65. doi: 10.1016/j.bpj.2011.11.4007. Epub 2012 Jan 3.
6
KL₄ peptide induces reversible collapse structures on multiple length scales in model lung surfactant.KL4 肽在模型肺表面活性剂中诱导多个长度尺度上的可逆坍塌结构。
Biophys J. 2011 Dec 21;101(12):2957-65. doi: 10.1016/j.bpj.2011.10.050. Epub 2011 Dec 20.
7
Surfactant therapy for acute lung injury and acute respiratory distress syndrome.表面活性物质治疗急性肺损伤和急性呼吸窘迫综合征。
Crit Care Clin. 2011 Jul;27(3):525-59. doi: 10.1016/j.ccc.2011.04.005.
8
Biophysical mimicry of lung surfactant protein B by random nylon-3 copolymers.随机尼龙-3 共聚物对肺表面活性剂蛋白 B 的生物物理模拟。
J Am Chem Soc. 2010 Jun 16;132(23):7957-67. doi: 10.1021/ja909734n.
9
Surfactant composition and biophysical properties are important in clinical studies.表面活性剂的组成和生物物理特性在临床研究中很重要。
Am J Respir Crit Care Med. 2010 Apr 1;181(7):762; author reply 762-3. doi: 10.1164/ajrccm.181.7.762.
10
Critical structural and functional roles for the N-terminal insertion sequence in surfactant protein B analogs.N 端插入序列在表面活性蛋白 B 类似物中的关键结构和功能作用。
PLoS One. 2010 Jan 13;5(1):e8672. doi: 10.1371/journal.pone.0008672.

合成蛋白Mini - B与胆固醇对气液界面处模型肺表面活性剂混合物的联合作用。

Combined effect of synthetic protein, Mini-B, and cholesterol on a model lung surfactant mixture at the air-water interface.

作者信息

Chakraborty Aishik, Hui Erica, Waring Alan J, Dhar Prajnaparamita

机构信息

Department of Chemical Engineering, University of Kansas, KS 66045, United States.

Department of Medicine, Harbor UCLA Medical Center - LA BioMed, CA 90502, United States; Department of Physiology and Biophysics, University of California, Irvine, CA 92697, United States.

出版信息

Biochim Biophys Acta. 2016 Apr;1858(4):904-12. doi: 10.1016/j.bbamem.2016.01.008. Epub 2016 Jan 15.

DOI:10.1016/j.bbamem.2016.01.008
PMID:26775740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5705005/
Abstract

The overall goal of this work is to study the combined effects of Mini-B, a 34 residue synthetic analog of the lung surfactant protein SP-B, and cholesterol, a neutral lipid, on a model binary lipid mixture containing dipalmitolphosphatidylcholine (DPPC) and palmitoyl-oleoyl-phosphatidylglycerol (POPG), that is often used to mimic the primary phospholipid composition of lung surfactants. Using surface pressure vs. mean molecular area isotherms, fluorescence imaging and analysis of lipid domain size distributions; we report on changes in the structure, function and stability of the model lipid-protein films in the presence and absence of varying composition of cholesterol. Our results indicate that at low cholesterol concentrations, Mini-B can prevent cholesterol's tendency to lower the line tension between lipid domain boundaries, while maintaining Mini-B's ability to cause reversible collapse resulting in the formation of surface associated reservoirs. Our results also show that lowering the line tension between domains can adversely impact monolayer folding mechanisms. We propose that small amounts of cholesterol and synthetic protein Mini-B can together achieve the seemingly opposing requirements of efficient LS: fluid enough to flow at the air-water interface, while being rigid enough to oppose irreversible collapse at ultra-low surface tensions.

摘要

这项工作的总体目标是研究肺表面活性蛋白SP-B的34个残基合成类似物Mini-B和中性脂质胆固醇对含有二棕榈酰磷脂酰胆碱(DPPC)和棕榈酰油酰磷脂酰甘油(POPG)的模型二元脂质混合物的联合作用,该混合物常用于模拟肺表面活性剂的主要磷脂组成。通过表面压力与平均分子面积等温线、荧光成像以及脂质域大小分布分析;我们报告了在有无不同胆固醇组成情况下模型脂质-蛋白质膜结构、功能和稳定性的变化。我们的结果表明,在低胆固醇浓度下,Mini-B可以防止胆固醇降低脂质域边界间线张力的倾向,同时保持Mini-B引起可逆塌陷从而形成表面相关储库的能力。我们的结果还表明,降低域间线张力会对单层折叠机制产生不利影响。我们提出,少量胆固醇和合成蛋白Mini-B可以共同实现高效肺表面活性剂看似相互矛盾的要求:足够流体化以在气-水界面流动,同时足够刚性以抵抗超低表面张力下的不可逆塌陷。